NCT00332436已完成3 期
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 586
- 试验地点
- 1
- 主要终点
- IOP
研究概览
简要总结
The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
- •Patient requires IOP-lowering drug in both eyes
排除标准
- •Uncontrolled medical condition
- •Contraindication to beta-adrenoceptor antagonist or brimonidine therapy
结局指标
主要结局
IOP
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionOcular HypertensionNCT00332345Allergan73
已完成
3 期
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionOcular HypertensionNCT00332384Allergan573
已完成
3 期
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00652106Allergan432
已完成
不适用
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT01229462Allergan238
已完成
3 期
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsGlaucomaOcular HypertensionNCT00651612Allergan604